GlassScriptPhysician profile
Jonathan A Aliota
NPI 1598712812
$106,229.18
in general payments reported to CMS, 2019-2025
27 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $17K · 2021: $7,078 · 2022: $20K · 2023: $12K · 2024: $16K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $6,646 · Consulting Fee: $6,600 · Travel and Lodging: $4,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,125.00 |
| Food and Beverage | $6,646.47 |
| Consulting Fee | $6,600.00 |
| Travel and Lodging | $4,301.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $85,522.20 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Shockwave Medical, INC | $7,991.79 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $2,940.78 | 2019-2025 | Cardiomems, Esprit, Mitraclip |
| Medtronic, INC. | $1,773.19 | 2021-2025 | Venaseal, Harmony, Closurefast |
| Abiomed | $1,769.35 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $1,453.40 | 2020 | |
| Edwards Lifesciences Corporation | $1,110.35 | 2019-2024 | |
| Angiodynamics, INC. | $961.72 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Cordis US Corp. | $510.81 | 2024-2025 | Mynx Control |
| Digirad Health, INC | $263.66 | 2021 | |
| Janssen Pharmaceuticals, INC | $249.94 | 2021-2022 | |
| Saranas, INC. | $232.80 | 2021-2022 | |
| Cardiovascular Systems INC. | $185.16 | 2019 | |
| Ge Healthcare | $171.14 | 2025 | |
| Teleflex LLC | $169.70 | 2025 | Guideliner |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cagent Vascular INC | $151.63 | 2023-2024 | Serrantor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.64 | 2019-2024 | Lifevest |
| Philips North America LLC | $127.82 | 2019 | |
| Bard Peripheral Vascular, INC. | $111.68 | 2020-2021 | |
| Avinger INC. | $110.43 | 2022 | |
| Cvrx, INC. | $74.90 | 2024 | Barostim Neo System |
| Artivion, INC. | $63.86 | 2021 | |
| Biotronik INC. | $42.12 | 2019 | |
| Amgen INC. | $39.72 | 2020-2022 | |
| Pfizer INC. | $23.38 | 2020 | |
| Veryan Medical Incorporated | $15.58 | 2021 | |
| Esperion Therapeutics, INC. | $14.43 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Aliota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.